ELYM NASDAQ
Eliem Therapeutics, Inc.
1W: -14.4%
1M: -17.5%
3M: -49.5%
1Y: +55.7%
3Y: -77.7%
$5.11
Last traded 2024-10-28 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$168M
-22.8% ▼
5Y CAGR: +46.8%
Total Liabilities
$7M
+37.0% ▲
5Y CAGR: +18.9%
Shareholders Equity
$160M
-24.3% ▼
5Y CAGR: +49.4%
Cash & Investments
$101M
-33.0% ▼
5Y CAGR: +37.6%
Total Debt
$541K
+1.7% ▲
Net Debt
-$35M
+59.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $47M | $44M | $93M | $87M | $36M |
| Short-Term Investments | $90M | $80M | $14M | $64M | $65M |
| Cash & ST Investments | $136M | $124M | $107M | $151M | $101M |
| Net Receivables | $7M | $6M | $2M | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $852K | $3M | $586K | $4M | $5M |
| Total Current Assets | $148M | $134M | $110M | $155M | $106M |
| Property, Plant & Equip. | $0 | $471K | $199K | $490K | $793K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $25M | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $70K | $128K | $15K | $62M | $61M |
| Total Non-Current Assets | $25M | $599K | $214K | $62M | $62M |
| Total Assets | $173M | $135M | $110M | $217M | $168M |
| — Liabilities — | |||||
| Accounts Payable | $1M | $750K | $66K | $705K | $2M |
| Short-Term Debt | $0 | $300K | $334K | $157K | $256K |
| Deferred Revenue | $0 | $0 | -$66K | $0 | $0 |
| Other Current Liabilities | $0 | -$300K | -$196K | $4M | $7M |
| Total Current Liabilities | $6M | $6M | $3M | $5M | $7M |
| Long-Term Debt | $0 | $180K | $15K | $375K | $285K |
| Other Non-Current Liab. | $7K | -$180K | $7K | $0 | $0 |
| Total Non-Current Liabilities | $7K | $180K | $37K | $375K | $285K |
| Total Liabilities | $6M | $6M | $3M | $5M | $7M |
| — Equity — | |||||
| Common Stock | $3K | $3K | $3K | $7K | $5K |
| Retained Earnings | -$76M | -$121M | -$156M | -$230M | -$290M |
| Accumulated OCI | -$123K | -$358K | -$2K | $23K | $435K |
| Total Stockholders Equity | $167M | $129M | $108M | $212M | $160M |
| Total Liabilities & Equity | $173M | $135M | $110M | $217M | $168M |
| — Key Metrics — | |||||
| Total Debt | $0 | $480K | $349K | $532K | $541K |
| Net Debt | -$47M | -$43M | -$93M | -$87M | -$35M |
| Total Investments | $114M | $80M | $14M | $64M | $65M |